Skip to main content
Warning Date
    2007-04-28

Increased Incidence of Fractures in Female Patients Who Received Long-Term Treatment with Avandia® (rosiglitazone maleate)

2007-04-28

In agreement with European Regulatory Authorities, GlaxoSmithKline (GSK) is informing you of recent safety data concerning rosiglitazone-containing products, i.e., Avandia® (rosiglitazone maleate) Tablets, Avandamet® (rosiglitazone maleate and metformin hydrochloride) Tablets, and Avaglim® (rosiglitazone maleate and glimepiride) Tablets. The information could be summarized as follows:

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-04-28

Aranesp ® is ineffective for non- chemotherapy induced anemia.

2007-04-28

Amgen notified the oncology medical community of the results of a large, multicenter, randomized, placebo-controlled study showing that Aranesp ® (Darbepoetin alfa) was ineffective in reducing red blood cell transfusions or fatigue in patients with cancer who have anemia that is not due to concurrent chemotherapy.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-05-01

Warning from the Medicines and Medical Devices Safety Authority on five Chinese medicine products

2007-05-01

Director-General of Health, Stephen McKernan, is warning people about the potential health dangers associated with 5 Chinese medicine products which have been found to contain undeclared prescription medicines for weight loss and erectile dysfunction.

This statement about the 5 products is being issued by the Director-General under Section 98 of the Medicines Act 1981, following investigations by the Ministry of Health's medicines safety arm, Medsafe.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-05-06

New information update for Pioglitazone

2007-05-06

Takeda and FDA notified healthcare professionals of recent safety data concerning pioglitazone-containing products. The results of an analysis of the manufacturer's clinical trial database of pioglitazone showed more reports of fractures in female patients taking pioglitazone than those taking a comparator (either placebo or active). The majority of fractures observed in female patients were in the distal upper limb (forearm, hand and wrist) or distal lower limb (foot, ankle, fibula and tibia).

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-05-07

Alert about Urat Madu

2007-05-07

The Singapore Health Sciences Authority found Urat Madu capsules to be adulterated with the prescription drug sildenafil. Sildenafil citrate is indicated for the treatment of erectile dysfunction, and has been associated with serious adverse reactions. Sildenafil is not intended for self-care, and should only be taken under the guidance of a health care professional.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-05-08

Warning Against Buying Accutane and Its Generic Versions Online

2007-05-08

The U.S. Food & Drug Administration (FDA) is launching a special Web page to warn consumers about the dangers of buying isotretinoin (Accutane) online. Isotretinoin is a drug approved for the treatment of severe recalcitrant nodular acne that does not respond to antibiotics. Improperly used, isotretinoin can cause severe side effects, including birth defects. Serious mental health problems have also been reported with isotretinoin use.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-05-23

FDA Panel Urges Stronger Warnings for Anemia Drugs

2007-05-23

A U.S. Food and Drug Administration advisory panel on Thursday called for new warnings and additional safety studies on anemia drugs commonly used to treat patients undergoing kidney dialysis or chemotherapy.

These medications have been the subject of controversy since some of their dangerous side effects -- including the risk of heart attacks and stroke -- came to light earlier this year. In March, the FDA issued stronger label warnings for the popular drugs.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-05-23

FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications

2007-05-23

The U.S. Food and Drug Administration (FDA) today proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased risks of suicidal thinking and behavior, known as suicidality, in young adults ages 18 to 24 during initial treatment (generally the first one to two months).

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-05-23

Alert about counterfeit product named Xiaokeshuping Jiangtangning Jiaonang capsules

2007-05-23

The Hong Kong Department of Health (HKDH) found Xiaokeshuping Jiangtangning Jiaonang capsules to contain the undeclared pharmaceutical drugs phenformin, rosiglitazone, and glibenclamide, which may be used in diabetes to lower blood sugar. The HKDH conducted the analysis following receipt of a report that one woman in China had been hospitalized due to a serious hypoglycaemic attack (very low blood sugar) after using Xiaokeshuping Jiangtangning Jiaonang.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-06-01

"حجر السعادة" في محلات العطارة مستحضر عشبي سام يؤدي إلى تليف الكبد

2007-06-01

حذر خبراء في الصيدلة من الادعاءات التي يسوق لها أصحاب محلات العطارة لمنتجات عشبية (سامة)، ومستحضرات ضارة بالصحة.

وأكدوا ل"الرياض": أن حجر السعادة(حجر جهنم) والذي يؤكد المسوقون له بأنه علاج فعال ومضمون ولا يوجد له محاذير طبية، هو عبارة عن مجموعة من المواد الصمغية والتي تحتوي على مواد سامة لها آثار جانبية ضارة تؤدي إلى تليف الكبد، ومواد مهلوسة محظورة دوليا.

ويأتي هذا التحذير في الوقت الذي تسوق محلات العطارة لأعشاب وأدوية لمعالجة جميع الأمراض، في ظل غياب الجهات الرقابية.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Subscribe to Drugs